Anshu Srivastava
Overview
Explore the profile of Anshu Srivastava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
1261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Samanta A, Srivastava A, Mohindra S, Yadav R, Poddar U, Sen Sarma M, et al.
ACG Case Rep J
. 2024 Aug;
11(8):e01473.
PMID: 39176220
Portal cavernoma cholangiopathy refers to changes in the intrahepatic and extrahepatic biliary ducts in patients with extrahepatic portal venous obstruction. Spontaneous hemobilia in the setting of portal cavernoma cholangiopathy is...
12.
Vinayagamoorthy V, Srivastava A, Anuja A, Agarwal V, Marak R, Sen Sarma M, et al.
Clin Res Hepatol Gastroenterol
. 2024 Jul;
48(8):102432.
PMID: 39074717
Objective: Biomarkers with high accuracy for identification of infection in decompensated chronic liver disease (DCLD) are urgently needed. We compared the accuracy of neutrophilic cluster of differentiation 64 (nCD64) with...
13.
Ravindranath A, Srivastava A, Yachha S, Poddar U, Sarma M, Mathias A
J Clin Exp Hepatol
. 2024 Jul;
14(6):101452.
PMID: 39005950
Objective: Hepatic encephalopathy (HE) is a marker of poor prognosis in adults with chronic liver disease (CLD). We prospectively studied the prevalence and precipitants of HE in children with CLD...
14.
Bolia R, Goel A, Semwal P, Srivastava A
J Pediatr Gastroenterol Nutr
. 2024 Jul;
79(3):667-673.
PMID: 38966965
Significance of autoantibodies in pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) is unknown. Our aim was to determine the prevalence and significance of autoantibodies in MASLD. PubMed and Scopus were...
15.
Agrawal A, Srivastava A, Mishra P, Malik R, Agrawal V, Raj A, et al.
Pancreatology
. 2024 Jun;
24(6):817-826.
PMID: 38937206
Background And Objectives: The impact of chronic pancreatitis (CP) on quality of life (QOL) of children is not well established. Our objective was to evaluate the QOL, identify contributing factors,...
16.
Samanta A, Sen Sarma M, Singh S, Srivastava A, Poddar U, Mandelia A, et al.
Indian J Gastroenterol
. 2024 Jun;
43(6):1144-1155.
PMID: 38902474
Introduction: Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) is a rare entity that mimics various inflammatory strictures of the small intestine. Pediatric literature is scarce. We analyzed the clinical, radiological, endoscopic...
17.
Zhang L, El-Shabrawi M, Baur L, Byrne C, Targher G, Kehar M, et al.
Med
. 2024 Apr;
5(7):797-815.e2.
PMID: 38677287
Background: Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in children and adolescents, particularly those with obesity. NAFLD is considered a hepatic manifestation of the metabolic syndrome due to its...
18.
Agrawal S, Arya A, Gautam A, Yadav R, Singh A, Boruah D, et al.
Cureus
. 2024 Apr;
16(3):e56443.
PMID: 38638772
Introduction Pancreatic fluid collection (PFC) is one of the most frequent complications associated with acute pancreatitis. The route of drainage is guided by the size and site of collection. The...
19.
Samanta A, Parveen N, Sen Sarma M, Poddar U, Srivastava A
J Clin Exp Hepatol
. 2024 Mar;
14(2):101290.
PMID: 38544763
Cholestatic liver diseases in children often have an underlying genetic defect. Genetic testing by next-generation sequencing has become a crucial part of the diagnostic armamentarium in such clinical scenarios. Here,...
20.